Mona Pourjafar
Overview
Explore the profile of Mona Pourjafar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
195
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pourjafar M, Tiwari V
Front Cell Dev Biol
. 2024 May;
12:1363361.
PMID: 38715921
Cell migration is fundamental to both development and adult physiology, including gastrulation, brain development, angiogenesis, wound healing, bone remodeling, tissue homeostasis, and the immune response. Additionally, misguided cellular migration is...
2.
Pourjafar M, Saidijam M, Miehe M, Najafi R, Soleimani M, Spillner E
J Immunother
. 2023 Jul;
46(7):245-261.
PMID: 37493044
Breast cancer (BC) treatment has traditionally been challenging due to tumor heterogeneity. Bispecific antibodies (bsAbs) offer a promising approach for overcoming these challenges by targeting multiple specific epitopes. In the...
3.
Shokrollah N, Samadi P, Jalali A, Dalirfardouei R, Afshar S, Pourjafar M
Asian Pac J Cancer Prev
. 2023 Jun;
24(6):1993-2001.
PMID: 37378929
Objective: This study aimed to find the key genes and miRNAs as potential biomarkers related to the progression of colorectal cancer (CRC) from Crohn's disease (CD). Background: CD is widely...
4.
Pourjafar M, Miehe M, Najafi R, Soleimani M, Spillner E
Protein Expr Purif
. 2022 Aug;
199:106148.
PMID: 35940518
Minibodies (single-chain Fv-CH3) are fusion proteins of a single-chain variable fragment (scFv) to the human IgG1 CH3 domain. They exhibit superior properties as compared to whole antibodies due to their...
5.
Rezaeepoor M, Rashidi G, Pourjafar M, Mohammadi C, Solgi G, Najafi R
Biomed Res Int
. 2021 Aug;
2021:8507373.
PMID: 34337054
Semaphorin 4D (SEMA4D), a protein originally demonstrated to regulate the immune system and axonal growth cone collapse in the developing central nervous system, is overexpressed in various human malignancies, including...
6.
Manoochehri H, Gheitasi R, Pourjafar M, Amini R, Yazdi A
Med J Islam Repub Iran
. 2021 Jul;
35:85.
PMID: 34291009
Coronary artery disease (CAD), as a most common cause of death, is mainly caused by atherosclerosis. Due to the role of inflammation in the process of atherosclerosis, in the present...
7.
Shahnazari M, Samadi P, Pourjafar M, Jalali A
Future Oncol
. 2021 Jun;
17(24):3253-3270.
PMID: 34156258
Immunotherapy is becoming as a major treatment modality for multiple types of solid tumors, including subsets of colorectal cancers (CRCs). The successes with immunotherapy alone has largely been achieved in...
8.
Shahnazari M, Samadi P, Pourjafar M, Jalali A
Int Immunopharmacol
. 2020 Nov;
88:106944.
PMID: 33182032
Cancer vaccines are usually derived from the patient's tumor cells or the antigens found on their surface, which may help the immune system to identify and kill these malignant cells....
9.
Pourjafar M, Samadi P, Karami M, Najafi R
Biotechnol Appl Biochem
. 2020 Oct;
68(6):1313-1322.
PMID: 33086431
B-cell-specific Moloney leukemia virus insertion site 1 (BMI-1) is one of the stemness markers. The prognostic and clinicopathological effects of BMI-1 expression in colorectal cancer (CRC) have been in dispute...
10.
Pourjafar M, Samadi P, Saidijam M
Immunotherapy
. 2020 Oct;
12(17):1269-1286.
PMID: 33019839
Antibody-based targeted therapies have been able to target cancers with enhanced specificity and high efficacy. In this regard, identifying cancer markers (antigens) that are only present (tumor-specific antigens) or have...